Germany
Japan
United Kingdom
China
Antibodies
SARS-Cov-2 N protein Rabbit Polyclonal Antibody
| Applications | ELISA, ICC, IHC, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | Full length recombinant SARS-CoV-2 N protein produced in E.coli. |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
SARS-CoV-2 Spike Protein Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein of SARS-CoV-2 spike RBD protein and virion surface domain of membrane protein (M-protein) produced in HEK293 |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
SARS-CoV-2 N protein rabbit polyclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
SARS-CoV-2 N protein rabbit polyclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
SARS-CoV-2 Spike protein rabbit polyclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
SARS-CoV-2 Spike protein rabbit polyclonal antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
SDC1 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of SDC1 expressed in HEK293 cells |
SDC1 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of SDC1 expressed in HEK293 cells |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
PMS2 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PMS2 expressed in HEK293 cells |
PMS2 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PMS2 expressed in HEK293 cells |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
PAX2 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PAX2 expressed in HEK293 cells |
PAX2 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PAX2 expressed in HEK293 cells |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
PAX5 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PAX5 expressed in HEK293 cells |
PAX5 Rabbit Polyclonal Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This antibody is raised against a recombinant protein of PAX5 expressed in HEK293 cells |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Active filters
Applications
- ELISA
Filter by
Target Symbol
- S PROTEIN (135)
- IL6 (131)
- UCHL1 (125)
- LCN2 (113)
- GFAP (106)
- IL1RL1 (105)
- N PROTEIN (105)
- IL17A (98)
- S100A8/A9 (87)
- D-DIMER (83)
- MPO (81)
- SAA1 (81)
- FABP3 (71)
- MYBPC3 (63)
- REG1A (62)
- CAPSID (50)
- NEFL (49)
- IGG4 (38)
- H3C1 (37)
- NPPB (37)
- AMH (34)
- EGFR (32)
- POMC (29)
- ALB (28)
- PDCD1 (28)
- C3 (27)
- TNF (27)
- COL1A1 (26)
- EGF (26)
- S (26)
- CD80 (25)
- MAPT (25)
- GAG (24)
- PTH (24)
- EDN1 (23)
- F13A1 (23)
- FSHB (23)
- NPPA (23)
- IL2 (22)
- PON1 (22)
- SARS-COV-2 SPIKE PROTEIN (22)
- CD274 (21)
- IFNG (20)
- S100B (20)
- BRAF (19)
- CALCA (19)
- PDYN (19)
- FOLH1 (18)
- IL10 (18)
- LTF (18)
- RBP4 (18)
- B2M (17)
- CSF2 (17)
- IGF1 (17)
- IL7 (17)
- INS (17)
- KITLG (17)
- PENK (17)
- SARS-COV-2 N PROTEIN (17)
- V5 (17)
- CD44 (16)
- HIS (16)
- MUC1 (16)
- COL4A1 (15)
- CXCL12 (15)
- FN1 (15)
- GCG (15)
- IL12A (15)
- IL3 (15)
- AFP (14)
- CCL2 (14)
- CD5 (14)
- IL4 (14)
- IL9 (14)
- MYC (14)
- TP63 (14)
- CD1C (13)
- CRP (13)
- EFNA2 (13)
- EPHX1 (13)
- HA (13)
- KLK3 (13)
- MSMB (13)
- NME1 (13)
- TLE1 (13)
- ADCYAP1 (12)
- CCL3 (12)
- GAL (12)
- GHRL (12)
- HIST1H3A (12)
- IAPP (12)
- MAPK8 (12)
- PRL (12)
- AGT (11)
- AKT1 (11)
- CHGA (11)
- DDK (11)
- GAPDH (11)
- IL1B (11)
- KLK8 (11)
Reactivities
- Human (5446)
- Mouse (1718)
- Rat (1520)
- SARS-CoV-2 (271)
- Mammalian (127)
- Porcine (99)
- Murine (82)
- Monkey (79)
- Bovine (58)
- Dog (49)
- HIV (49)
- Rabbit (25)
- Virus (24)
- Canine (19)
- Pig (12)
- Chicken (11)
- Primate (11)
- C-term DDK (10)
- Feline (9)
- Guinea Pig (9)
- Vertebrates (9)
- Cow (8)
- Goat (8)
- SARS-CoV (8)
- Sheep (8)
- Broad (5)
- Chimpanzee (5)
- Escherichia coli (3)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Zebrafish (3)
- Avian (2)
- Bacteria (2)
- Cynomolgus (2)
- Dengue virus (2)
- Ferret (2)
- Horse (2)
- Insect (2)
- N-term and C-term DDK (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- 5-FAM (1)
- Bacillus Antracis (1)
- Biotin (1)
- C. elegans (1)
- Digoxin (1)
- FITC (1)
- Fish (1)
- Fusion proteins containing the Flag Tag (1)
- Horseradish Peroxidase (1)
- Staphylococcus aureus (1)
- Xenopus (1)
Antibody Hosts
Isotypes
- IgG1 (5108)
- IgG (4822)
- IgG2a (1139)
- IgG2b (909)
- IgG, kappa (166)
- IgG1, kappa (124)
- IgM (113)
- IgG3 (90)
- IgG2a, kappa (35)
- Ig (34)
- IgG2 (24)
- Fab fragment, kappa (19)
- IgG2b, kappa (15)
- IgG1, lambda (11)
- IgY (10)
- IgG1-Fc Fusion (8)
- IgG2c (6)
- IgG3, kappa (5)
- IgG4 (5)
- IgM, kappa (5)
- IgA-Fc Fusion (4)
- IgG-Fc Fusion (4)
- IgM-Fc Fusion (4)
- IgA (3)
- IgE (3)
- cocktail (3)
- IgG2, kappa (2)
- IgG2a, lambda (2)
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho-specific (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (3786)
- Secreted Protein (1557)
- Transmembrane (1184)
- ES Cell Differentiation/IPS (592)
- Transcription Factors (531)
- Protease (363)
- Protein Kinase (310)
- Stem cell - Pluripotency (200)
- Adult stem cells (121)
- Embryonic stem cells (95)
- Cancer stem cells (72)
- Induced pluripotent stem cells (67)
- Stem cell relevant signaling - JAK/STAT signaling pathway (62)
- GPCR (54)
- Stem cell relevant signaling - DSL/Notch pathway (37)
- Phosphatase (36)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (32)
- Stem cell relevant signaling - Wnt Signaling pathway (23)
- Ion Channels: Other (19)
- Nuclear Hormone Receptor (19)
- P450 (14)
- Ion Channels: Cys-loop Receptors (6)
- Ion Channels: Glutamate Receptors (4)
- Ion Channels: Potassium (4)
- Ion Channels: Transient receptor potential (4)
- Ion Channels: Cyclic nucleotide gated (1)
- Ion Channels: Sodium (1)
Pathways
- Cytokine-cytokine receptor interaction (726)
- Pathways in cancer (579)
- Jak-STAT signaling pathway (370)
- Metabolic pathways (353)
- MAPK signaling pathway (314)
- Focal adhesion (299)
- Hematopoietic cell lineage (282)
- Toll-like receptor signaling pathway (280)
- Hypertrophic cardiomyopathy (HCM) (233)
- Chemokine signaling pathway (231)
- Prostate cancer (219)
- Regulation of actin cytoskeleton (219)
- NOD-like receptor signaling pathway (211)
- ErbB signaling pathway (185)
- Graft-versus-host disease (180)
- T cell receptor signaling pathway (180)
- Melanoma (175)
- Prion diseases (173)
- Systemic lupus erythematosus (165)
- Colorectal cancer (160)
- Pancreatic cancer (159)
- Endometrial cancer (158)
- Glioma (156)
- Bladder cancer (152)
- Cytosolic DNA-sensing pathway (149)
- Parkinson's disease (144)
- Neurotrophin signaling pathway (143)
- Complement and coagulation cascades (138)
- Non-small cell lung cancer (138)
- Natural killer cell mediated cytotoxicity (134)
- Chronic myeloid leukemia (133)
- GnRH signaling pathway (130)
- Cell adhesion molecules (CAMs) (128)
- Gap junction (125)
- Insulin signaling pathway (124)
- TGF-beta signaling pathway (124)
- Acute myeloid leukemia (120)
- Progesterone-mediated oocyte maturation (119)
- Endocytosis (117)
- Fc epsilon RI signaling pathway (117)
- Neuroactive ligand-receptor interaction (117)
- PPAR signaling pathway (116)
- Dilated cardiomyopathy (114)
- Alzheimer's disease (109)
- Cell cycle (106)
- Renal cell carcinoma (106)
- Amyotrophic lateral sclerosis (ALS) (105)
- ECM-receptor interaction (103)
- Apoptosis (99)
- Wnt signaling pathway (96)
- Small cell lung cancer (91)
- Type I diabetes mellitus (89)
- Melanogenesis (87)
- Adipocytokine signaling pathway (86)
- Adherens junction (84)
- Allograft rejection (84)
- B cell receptor signaling pathway (82)
- Epithelial cell signaling in Helicobacter pylori infection (80)
- Fc gamma R-mediated phagocytosis (76)
- RIG-I-like receptor signaling pathway (76)
- Thyroid cancer (76)
- mTOR signaling pathway (74)
- Axon guidance (73)
- Long-term depression (73)
- Vascular smooth muscle contraction (73)
- Leukocyte transendothelial migration (70)
- Oocyte meiosis (70)
- Autoimmune thyroid disease (68)
- Tight junction (66)
- Type II diabetes mellitus (65)
- Calcium signaling pathway (64)
- Long-term potentiation (64)
- p53 signaling pathway (64)
- VEGF signaling pathway (62)
- Glycolysis / Gluconeogenesis (59)
- Huntington's disease (54)
- Dorso-ventral axis formation (51)
- Pathogenic Escherichia coli infection (49)
- Viral myocarditis (49)
- Antigen processing and presentation (45)
- Purine metabolism (45)
- Asthma (42)
- Arginine and proline metabolism (40)
- Cysteine and methionine metabolism (39)
- Notch signaling pathway (39)
- Glutathione metabolism (38)
- Ubiquitin mediated proteolysis (38)
- Metabolism of xenobiotics by cytochrome P450 (37)
- Pyruvate metabolism (37)
- Basal cell carcinoma (29)
- Proteasome (29)
- Regulation of autophagy (29)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Pyrimidine metabolism (26)
- Citrate cycle (TCA cycle) (24)
- Maturity onset diabetes of the young (24)
- Tryptophan metabolism (24)
- Lysosome (23)
- Arachidonic acid metabolism (22)
- Cardiac muscle contraction (21)
- Hedgehog signaling pathway (21)
- Nitrogen metabolism (21)
- Drug metabolism - cytochrome P450 (19)
- Butanoate metabolism (18)
- Glycine (18)
- Propanoate metabolism (18)
- Valine (18)
- leucine and isoleucine degradation (18)
- serine and threonine metabolism (18)
- Base excision repair (17)
- Fatty acid metabolism (17)
- Tyrosine metabolism (17)
- One carbon pool by folate (16)
- RNA degradation (16)
- Fructose and mannose metabolism (15)
- Lysine degradation (15)
- Spliceosome (15)
- Vibrio cholerae infection (15)
- beta-Alanine metabolism (15)
- Alanine (14)
- aspartate and glutamate metabolism (14)
- Histidine metabolism (13)
- Nucleotide excision repair (13)
- Pentose phosphate pathway (13)
- Biosynthesis of unsaturated fatty acids (12)
- Oxidative phosphorylation (12)
- Primary immunodeficiency (12)
- Renin-angiotensin system (12)
- Sphingolipid metabolism (12)
- Nicotinate and nicotinamide metabolism (11)
- Phenylalanine metabolism (11)
- ABC transporters (10)
- Amino sugar and nucleotide sugar metabolism (10)
- Mismatch repair (10)
- Folate biosynthesis (9)
- Homologous recombination (9)
- Non-homologous end-joining (9)
- Olfactory transduction (9)
- Phosphatidylinositol signaling system (9)
- Porphyrin and chlorophyll metabolism (9)
- Riboflavin metabolism (9)
- Starch and sucrose metabolism (9)
- Glycerolipid metabolism (8)
- Glyoxylate and dicarboxylate metabolism (8)
- Methane metabolism (8)
- Retinol metabolism (8)
- Ribosome (8)
- SNARE interactions in vesicular transport (8)
- Selenoamino acid metabolism (8)
- Cyanoamino acid metabolism (7)
- Drug metabolism - other enzymes (7)
- Linoleic acid metabolism (7)
- N-Glycan biosynthesis (7)
- Terpenoid backbone biosynthesis (7)
- Aminoacyl-tRNA biosynthesis (6)
- DNA replication (6)
- Glycerophospholipid metabolism (6)
- Primary bile acid biosynthesis (6)
- Taurine and hypotaurine metabolism (6)
- Ether lipid metabolism (5)
- Galactose metabolism (5)
- Synthesis and degradation of ketone bodies (5)
- Caffeine metabolism (4)
- Inositol phosphate metabolism (4)
- Limonene and pinene degradation (4)
- Androgen and estrogen metabolism (3)
- RNA polymerase (3)
- Taste transduction (3)
- Vitamin B6 metabolism (3)
- Ascorbate and aldarate metabolism (2)
- C21-Steroid hormone metabolism (2)
- Circadian rhythm - mammal (2)
- Fatty acid elongation in mitochondria (2)
- O-Glycan biosynthesis (2)
- Pantothenate and CoA biosynthesis (2)
- Pentose and glucuronate interconversions (2)
- alpha-Linolenic acid metabolism (2)
- leucine and isoleucine biosynthesis (2)
- D-Glutamine and D-glutamate metabolism (1)
- Fatty acid biosynthesis (1)
- Lysine biosynthesis (1)
- Other glycan degradation (1)
- Phenylalanine (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)